New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma
felixioncool / Pixabay

New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma

According to a story from bioengineer.org, it has long been known that people with the rare disorder Duchenne muscular dystrophy are at a greater risk of developing a rare cancer…

Continue Reading New Research Highlights the Link Between Duchenne Muscular Dystrophy and Rhabdomyosarcoma
Why are Poor Black and Hispanic Children Dying at Higher Rates From Childhood Cancer Than Whites?
source: pixabay.com

Why are Poor Black and Hispanic Children Dying at Higher Rates From Childhood Cancer Than Whites?

What is the Disparity? America is greatly divided by many things and race has always been one of them. Not only are there large social and economic divides among racial…

Continue Reading Why are Poor Black and Hispanic Children Dying at Higher Rates From Childhood Cancer Than Whites?

30 Million Euros Allocated to Fund Precision Medicine Research Projects for Neurodegenerative Diseases

Precision mNedicine is the latest craze in rare disease research. Thankfully for patients, it is completely, 100% centered on improving the quality of their care. Unlike most typical healthcare practices,…

Continue Reading 30 Million Euros Allocated to Fund Precision Medicine Research Projects for Neurodegenerative Diseases

Massachusetts Proposes Installment Plan to Cover Cost of Gene Therapy for Spinal Muscular Atrophy

Spinal muscular atrophy (SMA) is a genetic condition which affects between 10,000 and 25,000 in the United States. While rare, it is currently the leading genetic cause of infant mortality. But,…

Continue Reading Massachusetts Proposes Installment Plan to Cover Cost of Gene Therapy for Spinal Muscular Atrophy

First Patient Dosed in Phase 1b Trial Aiming to Inhibit the Progression of Nonalcoholic Steatohepatitis

Nonalcoholic fatty liver disease (NAFLD) is a condition which causes fat to accumulate in the liver. Nonalcoholic steatohepatitis (NASH) is a severe form of the disease in which the patient also…

Continue Reading First Patient Dosed in Phase 1b Trial Aiming to Inhibit the Progression of Nonalcoholic Steatohepatitis

Funds Raised For Researching Mucopolysaccharidosis and Other Rare Diseases

Xconomy.com has just released that funds have been raised for a variety of companies investigating therapies for rare conditions. Unfortunately, novel therapies and inventions cost million of dollars to develop. Thankfully,…

Continue Reading Funds Raised For Researching Mucopolysaccharidosis and Other Rare Diseases
A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!
source: pixabay.com

A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!

Myelodysplastic syndromes (MDS) is the name used to describe a group of stem cell disorders in which the body can't produce an adequate amount of platelets and blood cells. Currently,…

Continue Reading A New Phase II Trial for Myelodysplastic Syndromes and Acute Myeloid Leukemia is Underway!

Australian Government Initiates New Trial Program to Support Individuals Recently Diagnosed with a Rare Disease

Being diagnosed with any serious condition can be scary, overwhelming, and full of unknowns. For those who are diagnosed with a rare disease such as Duchenne muscular dystrophy, spinal muscular atrophy,…

Continue Reading Australian Government Initiates New Trial Program to Support Individuals Recently Diagnosed with a Rare Disease

A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Each year the Food and Drug Administration approves dozens of new therapies to fulfill unmet needs for various patient populations. It's just been published that in 2018 they approved a…

Continue Reading A Recap on 2018: Record Number of Drugs Approved by the FDA for Rare Diseases

Positive Results for aTTP Announced by New England Journal of Medicine

Patients with acquired thrombotic thrombocytopenic purpura (aTTP) showed a significantly improved platelet count response after treatment with Cablivi® according to the New England Journal of Medicine's Phase 3 trial results. A…

Continue Reading Positive Results for aTTP Announced by New England Journal of Medicine

New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?

As discussed in a recent article on PatientWorthy the FDNA has recently developed a new kind of algorithm which can diagnose rare genetic conditions such as Angelman syndrome, Williams syndrome, and Fragile X syndrome using…

Continue Reading New Technology for Diagnosing Rare Conditions by Photograph May Foster Employment Discrimination?